Viking Therapeutics, Inc. (VKTX)
33.23
-0.66
(-1.95%)
USD |
NASDAQ |
Aug 24, 16:00
33.25
+0.02
(+0.06%)
After-Hours: 20:00
Viking Therapeutics Price to Book Value : 9.494 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 9.494 |
| August 21, 2026 | 9.682 |
| August 20, 2026 | 9.816 |
| August 19, 2026 | 10.28 |
| August 18, 2026 | 9.534 |
| August 17, 2026 | 9.608 |
| August 14, 2026 | 9.482 |
| August 13, 2026 | 9.411 |
| August 12, 2026 | 9.719 |
| August 11, 2026 | 9.656 |
| August 10, 2026 | 9.839 |
| August 07, 2026 | 9.788 |
| August 06, 2026 | 9.514 |
| August 05, 2026 | 9.574 |
| August 04, 2026 | 9.411 |
| August 03, 2026 | 9.316 |
| July 31, 2026 | 9.068 |
| July 30, 2026 | 9.459 |
| July 29, 2026 | 9.551 |
| July 28, 2026 | 9.674 |
| July 27, 2026 | 9.962 |
| July 24, 2026 | 9.939 |
| July 23, 2026 | 10.11 |
| July 22, 2026 | 10.66 |
| July 21, 2026 | 10.84 |
| Date | Value |
|---|---|
| July 20, 2026 | 10.39 |
| July 17, 2026 | 10.59 |
| July 16, 2026 | 10.39 |
| July 15, 2026 | 10.80 |
| July 14, 2026 | 10.85 |
| July 13, 2026 | 10.89 |
| July 10, 2026 | 11.10 |
| July 09, 2026 | 11.75 |
| July 08, 2026 | 11.42 |
| July 07, 2026 | 12.04 |
| July 06, 2026 | 11.06 |
| July 02, 2026 | 10.70 |
| July 01, 2026 | 10.71 |
| June 30, 2026 | 11.14 |
| June 29, 2026 | 9.130 |
| June 26, 2026 | 8.784 |
| June 25, 2026 | 8.541 |
| June 24, 2026 | 8.744 |
| June 23, 2026 | 8.038 |
| June 22, 2026 | 7.474 |
| June 18, 2026 | 7.015 |
| June 17, 2026 | 6.994 |
| June 16, 2026 | 6.846 |
| June 15, 2026 | 6.842 |
| June 12, 2026 | 6.638 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vertex Pharmaceuticals, Inc. | 6.852 |
| Eli Lilly & Co. | 34.65 |
| Regeneron Pharmaceuticals, Inc. | 2.702 |
| Skye Bioscience, Inc. | -- |
| Eledon Pharmaceuticals, Inc. | 8.355 |
Price to Book Value Related Metrics
| PEG Ratio | -0.035 |
| Price | 33.23 |
| Earnings Yield | -14.03% |
| Market Cap | 3.876B |
| PEGY Ratio | -0.035 |